In a crowded rosacea topical market, Hovione is trialing a new topical antibiotic formulation – 1% vs. 3% minocycline gel. HY01 is said to be based on a “proprietary formulation of crystalline minocycline base and oil-based excipients.” In the topical anti-papule and pustule market, this new formulation of Minocycline is up against the industry heavyweights […]

More...